Neogenomics, Inc. operates in the Testing laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Neogenomics with three other
miscellaneous service companies in North America:
sales of $417.20 million
of which 81%
was Engineering and other scientific),
of which 91%
was Tuition revenue, net), and
of which 100%
was EDUCATIONAL SERVICES).
Neogenomics reported sales of $408.83 million
December of 2019.
increase of 47.7%
versus 2018, when the company's sales were $276.74 million.
Sales at Neogenomics have increased during each of the previous five years
(and since 2014, sales have increased a total of 370%).
Sales of Clinical Testing saw an increase
49.3% in 2019, from
$241.87 million to $361.16 million.